A Multi-center Long Term Efficacy Trial of the GFX For Reduction of Glabellar Furrowing

PHASE4CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Glabellar Furrowing
Interventions
DEVICE

GFX

The GFX system employs minimally invasive technique utilizing Bi-polar (radio frequency) RF technology. GFX ablates nerves activating the muscles that cause glabellar furrowing.

Trial Locations (10)

29203

J. Smythe Rich, III, M.D, Columbia

30327

Foad Nahai, M.D., F.A.C.S., Atlanta

33613

Michael E. Jansin, MD, Tampa

53217

Roger C. Mixter, MD, Milwaukee

60035

Steven P. Block, MD, Highland Park

65807

Keith LaFerriere, MD, Springfield

77030

Russell W. Kridel, MD, Houston

90212

Paul S. Nassif, MD, FACS, Beverly Hills

94401

James Newman, San Mateo

M2N 1M9

David A. Ellis, MD, Toronto

All Listed Sponsors
lead

Advanced Cosmetic Intervention

INDUSTRY

NCT00611273 - A Multi-center Long Term Efficacy Trial of the GFX For Reduction of Glabellar Furrowing | Biotech Hunter | Biotech Hunter